Skip to main content

Published locations for Frontline bevacizumab fails to boost glioblastoma survival in key trials

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Frontline bevacizumab fails to boost glioblastoma survival in key trials

User login

  • Reset your password
  • /content/frontline-bevacizumab-fails-boost-glioblastoma-survival-key-trials
  • /internalmedicinenews/article/59015/neuro-oncology/frontline-bevacizumab-fails-boost-glioblastoma
  • /oncologypractice/article/59015/neuro-oncology/frontline-bevacizumab-fails-boost-glioblastoma
  • /hematology-oncology/article/59015/neuro-oncology/frontline-bevacizumab-fails-boost-glioblastoma
  • /internalmedicine/article/59015/neuro-oncology/frontline-bevacizumab-fails-boost-glioblastoma
  • /neurology/article/59015/neuro-oncology/frontline-bevacizumab-fails-boost-glioblastoma-survival-key
  • /clinicalneurologynews/article/59015/neuro-oncology/frontline-bevacizumab-fails-boost-glioblastoma